microbiome therapeutics

News

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

Events

Partner Content

Discover the Next Generation of Microbiome Therapeutics

News

Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.